Be the first to know

Never miss an update from CSL. Did you know that during reporting season, the announcements from ASX:CSL often move the market?

CSL (ASX:CSL) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow CSL

CSL (CSL)

AU ASX:CSL (130.3B)

297.46
+7.94 (2.67%)
4pm Friday Jul 03 AEST
LOADING
Loading price chart..

Summary

Current Price: $297.46
52w High/Low: $215.24 - 342.75
Market Cap: 130.3B
Price/Earnings: 72.79
Dividend Yield: 0.60%
Volume/Average: 812K - $933
CSL (ASX:CSL) Company Logo

Listed in 1994

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
CSL (ASX:CSL) Company Logo

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.

Annual Reports

CSL Annual Report 2018/19 Sep 5th 2019
2019
(6.8mb)
CSL Annual Report to shareholders Sep 13th 2018
2018
(5.8mb)
Annual Report to Shareholders Sep 14th 2017
2017
(5.8mb)
Annual Report to shareholders Sep 8th 2016
2016
(5.5mb)
Annual Report to shareholders Sep 11th 2015
2015
(4.3mb)

Dividend History

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Dividend Yield
3.3%
 
0.6%
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL's dividend yield of 0.6% is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Implied Growth
36.8%
 
7.9%
 
 
Industry Avg
CSL

ATTRACTIVE: CSL exhibits an implied growth ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. CSL calculation: 10% - ($6.32 / $297.46) = 7.9% more
Price / Book
6.0
 
15.6
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL exhibits a price/book ratio which exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Earnings
19.4
 
47.0
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL's price/earnings ratio of 47 exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Sales
15.9
 
10.6
 
 
Industry Avg
CSL

ATTRACTIVE: CSL exhibits a price/sales ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more

Company News

Is the CSL share price fairly valued?
July 2nd, 2020 - Motley Fool

Is the CSL Limited (ASX: CSL) share price fairly valued in today's market? CSL is a growing company, but it could be priced to perfection. The post Is the CSL share price fairly valued? appeared first on Motley Fool Australia.

Fund managers have been snapping up Sonic and these ASX 200 stocks
July 2nd, 2020 - Motley Fool

Fund managers have been snapping up ASX shares with their average cash balance dropping again in May to a more than two-year low. The post Fund managers have been snapping up Sonic and these ASX 200 stocks appeared first on Motley Fool Australia.

Why I would buy CSL and these ASX blue chip shares in FY 2021
July 1st, 2020 - Motley Fool

Here's why I think CSL Limited (ASX:CSL) and these ASX blue chip shares could be market beaters in FY 2021 and beyond... The post Why I would buy CSL and these ASX blue chip shares in FY 2021 appeared first on Motley Fool Australia.

ASX 200 stocks to watch for FY2021
July 1st, 2020 - Motley Fool

The last financial year started so promising but fizzled. The silver lining is that FY21 is likely to be better and here are some ASX stocks to consider for your portfolio. The post ASX 200 stocks to watch for FY2021 appeared first on Motley Fool Australia.

Up nearly 33% in 12 months. Can the CSL share price climb higher?
June 30th, 2020 - Motley Fool

The CSL Limited (ASX: CSL) share price rocketed 32.53% higher in FY20 but is the Aussie biotech positioned for more growth this year? The post Up nearly 33% in 12 months. Can the CSL share price climb higher? appeared first on Motley Fool Australia.

Top ASX Stock Picks for July 2020
June 30th, 2020 - Motley Fool

We asked our Foolish writers to pick their favourite ASX stocks to buy in July 2020. Here is what they came up with… The post Top ASX Stock Picks for July 2020 appeared first on Motley Fool Australia.

Why I would buy and hold CSL and this quality ASX 200 share
June 30th, 2020 - Motley Fool

Here's why I think CSL Limited (ASX:CSL) and A2 Milk Company Ltd (ASX:A2M) shares would be great buy and hold options for investors... The post Why I would buy and hold CSL and this quality ASX 200 share appeared first on Motley Fool Australia.

S&P/ASX 200 index to pop Tuesday morning – stocks to watch
June 29th, 2020

The S&P/ASX 200 (INDEXASX: XJO) is expected to jump this morning, according to data from the Sydney Futures Exchange. Here's everything you need to know.